A placebo-controlled, parallel group multicenter phase III trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED)

Trial Profile

A placebo-controlled, parallel group multicenter phase III trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED)

Planning
Phase of Trial: Phase III

Latest Information Update: 30 Mar 2017

At a glance

  • Drugs Nitroglycerin (Primary)
  • Indications Erectile dysfunction
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 30 Mar 2017 New trial record
    • 23 Mar 2017 According to a Futura Medical media release, the company expects initiation of this trial in the fourth quarter of 2017, completion of the trial in the fourth quarter of 2018 and regulatory submissions in the second quarter of 2019.
    • 23 Mar 2017 According to a Futura Medical media release, the company is consulting with the UK and US regulatory authorities to finalize design and timing of this study.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top